Blog Archive

Emerging pharmacology and patient expectations

[vc_row full_width=”stretch_row” gap=”35″][vc_column][vc_column_text]The first half of 2022 saw several encouraging developments in the pharmaceutical sector. In June alone, we learned that all of the rectal cancer patients in…

From the desk of the President: Applied Policy welcomes Steven Johnson as health policy director

[vc_row full_width=”stretch_row” gap=”35″][vc_column][vc_column_text] As the Applied Policy team grows to better serve our clients, I am pleased to announce the appointment of Steven Johnson as Health Policy Director.…

IVD test reimbursement: Coverage is key

[vc_row full_width=”stretch_row” gap=”35″][vc_column][vc_column_text]In June, Applied Policy’s diagnostic experts introduced a new series, “IVD Test Reimbursement: Coverage, Coding, and Payment.” For our July edition, we take a deeper dive…

CMS holds second webinar on unwinding PHE

[vc_row full_width=”stretch_row” gap=”35″][vc_column][vc_column_text]On June 22, 2022, the Centers for Medicare & Medicaid Services (CMS) held its second monthly webinar on unwinding the COVID-19 public health emergency (PHE) flexibilities…

CMS predicts payment increase for ESRD facilities in CY 2023, adds quality incentive flexibilities, Includes ETC Model Changes

[vc_row full_width=”stretch_row” gap=”35″][vc_column][vc_column_text] On June 21, the Centers for Medicare & Medicaid Services (CMS) issued the calendar year (CY) 2023 proposed End-Stage Renal Disease (ESRD) Prospective Payment System…

Medicare reimbursement requirements for in vitro diagnostic (IVD) tests

[vc_row full_width=”stretch_row” gap=”35″][vc_column][vc_column_text]At Applied Policy, we assist many clients in understanding how Medicare reimburses for in vitro diagnostic (IVD) lab tests. Why do we focus on Medicare? Because…

VALID v. Vital update

[vc_row full_width=”stretch_row” gap=”35″][vc_column][vc_column_text]Current Food and Drug Administration (FDA) user fees for prescription drugs, generic drugs, biosimilars, and medical devices are set to expire at the end of September…

CMS hosts webinar on unwinding the public health emergency

[vc_row full_width=”stretch_row” gap=”35″][vc_column][vc_column_text]On May 25, 2022, the Centers for Medicare & Medicaid Services (CMS) held its first monthly webinar on unwinding the COVID-19 public health emergency (PHE) flexibilities…

Nurse retention—it’s not just about the money

[vc_row full_width=”stretch_row” gap=”35″][vc_column][vc_column_text]They are making headlines across the country and prompting more than a few people to reconsider career choices—the generous sign-on bonuses hospitals and healthcare systems are…

A new era in medical devices

[vc_row full_width=”stretch_row” gap=”35″][vc_column][vc_column_text]A portable walk-in whirlpool tub, a device designed to play “multi-talker babble” in a patient’s ear when they speak, and a personal prosthetic exoskeleton system—these are…

Realizing the potential of telehealth

[vc_row full_width=”stretch_row” gap=”35″][vc_column][vc_column_text]A discussion of telehealth is important both in terms of telehealth’s potential to improve patient access to care and because of uncertainty over its future after…

The unlikely roots of CMS’s commitment to health equity

[vc_row full_width=”stretch_row” gap=”35″][vc_column][vc_column_text]The Centers for Medicare & Medicaid Services has declared health equity the first pillar in its 2022 Strategic Plan and the commitment is being reflected across…

impact your business